California vs South Carolina on USAspending: $39.5B against $3.9B

Biological products on a $3.9B Lowcountry file

South Carolina’s lead NAICS is biological product (except diagnostic) manufacturing. That biologics label sits on $3.9B against California’s $39.5B commercial-construction peak. A biologics mix is a different federal buying pattern than a facilities mix. The packet names those peaks; it does not give shares or plant lists.

South Carolina files 129,440 awards. California files 639,340. South Carolina’s row count is about 20 percent of California’s; its dollar stock is about 10 percent. The Lowcountry tape is busy relative to dollars. Use the California and South Carolina state hubs for agencies and recipients. Cite USAspending.gov.

South Carolina’s $3.9B biologics stock on 5,478,831 residents is a busy 129,440-row tape with a cool $83.98 reading; California’s $39.5B construction-led stock on 39,431,263 residents carries $135.64. FY2026 of $460.1M versus $5.3B does not reorder that ranking.

A $83.98 reading on 5.5 million people

South Carolina’s 5,478,831 residents are about 14 percent of California’s 39,431,263. South Carolina’s $3.9B is about 10 percent of California’s $39.5B. Dollars lag population, which is why $83.98 trails $135.64. South Carolina is a midsize Census file with a cooler obligation load per resident than California.

Keep those per-capita figures labeled as Census-based packet figures on USAspending.gov obligations. They are not outlays per resident. A biologics peak does not by itself set statewide intensity when the stacked stock is $3.9B.

FY2026: $460.1M versus $5.3B

Fiscal year 2026 obligations are $5.3B in California and $460.1M in South Carolina. South Carolina’s latest-year amount is a modest slice of $3.9B. California’s $5.3B is a modest slice of $39.5B. Recency preserves California’s lead.

Treat FY2026 as a recency slice of obligations, not Treasury cash. Do not divide $5.3B or $460.1M by 639,340 or 129,440 all-years awards. Spending per capita of $135.64 and $83.98 already uses Census denominators of 39,431,263 and 5,478,831.

Biologics versus federal buildings

Biological product manufacturing and commercial and institutional building construction are different NAICS families. Readers should not treat South Carolina’s $3.9B as a smaller California. The stacks differ in size, intensity, and lead industry. The 129,440 and 639,340 rows include many codes beyond those peaks.

Place-of-performance for biologics can sit at a plant. The packet does not reallocate suppliers. Outlays are a different USAspending.gov series.

Biologics on a busy $3.9B Lowcountry tape

South Carolina’s biological-product-except-diagnostic peak on $3.9B with 129,440 awards is a biologics-manufacturing signature with a busy tape relative to dollars. California’s 639,340 awards on $39.5B remain the larger file, with a commercial-construction peak. South Carolina’s row share is larger than its dollar share. Spending per capita of $83.98 on 5,478,831 residents trails California’s $135.64 on 39,431,263.

FY2026 of $460.1M versus $5.3B restates California’s recency lead. South Carolina’s latest-year amount is a modest slice of $3.9B. Cite USAspending.gov for obligations. Do not convert biologics dollars into outlays, and do not divide $460.1M by 129,440 all-years awards.

Place-of-performance for biological product manufacturing can sit at a plant. The packet does not reallocate suppliers. Use the California and South Carolina hubs for agencies and recipients. The comparison hub holds the $39.5B versus $3.9B tables. Keep 129,440 versus 639,340 labeled as all-years award counts. Construction versus biologics are mix tags on different stacks.

South Carolina’s 129,440 awards on 5,478,831 residents under $83.98 per capita describe a biologics-led tape that is busy relative to $3.9B. California’s $39.5B, 639,340 awards, and $135.64 on 39,431,263 residents remain the scale and intensity side. FY2026 of $460.1M versus $5.3B restates recency. Biological product manufacturing is a mix tag. Cite USAspending.gov obligations only.

How to read California versus South Carolina

Read California first on stacked dollars ($39.5B vs $3.9B), spending per capita ($135.64 vs $83.98), award count (639,340 vs 129,440), and FY2026 ($5.3B vs $460.1M). Read South Carolina for the biological-product peak against California’s commercial-construction peak, and for a 129,440-row tape that is busy relative to $3.9B.

The comparison hub holds the tables. Outlays are not listed.

South Carolina’s 5,478,831 residents and California’s 39,431,263 residents set the $83.98 versus $135.64 denominators on $3.9B versus $39.5B. Award counts of 129,440 versus 639,340 and FY2026 of $460.1M versus $5.3B complete the comparison. Biological product manufacturing versus commercial construction remains the mix contrast. Cite USAspending.gov. Outlays are not listed.

Questions

Does California or South Carolina have more federal spending?

California leads stacked USAspending.gov obligations $39.5B to South Carolina’s $3.9B. California also leads spending per capita, $135.64 versus $83.98, on 39,431,263 residents against South Carolina’s 5,478,831. Award counts are 639,340 in California and 129,440 in South Carolina. FY2026 obligations are $5.3B in California and $460.1M in South Carolina.

What is South Carolina’s lead industry versus California?

South Carolina’s top industry is biological product (except diagnostic) manufacturing. California’s is commercial and institutional building construction. Those labels are the largest NAICS slices on $3.9B and $39.5B. Award counts are 129,440 in South Carolina and 639,340 in California. The figures are USAspending.gov obligations, not outlays.

Does South Carolina have a high award count relative to its dollars?

South Carolina files 129,440 awards on $3.9B against California’s 639,340 on $39.5B. South Carolina’s row share is larger than its dollar share. Spending per capita is $83.98 versus $135.64 on 5,478,831 versus 39,431,263 residents. These figures are USAspending.gov obligations, not outlays.

Are California vs South Carolina figures Treasury outlays?

No. The $39.5B and $3.9B totals, and FY2026 amounts of $5.3B and $460.1M, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($135.64 vs $83.98) uses Census population where present. Award counts in the packet are all-years totals, not a single fiscal year’s actions.